CORD-19:005c43980edf3fcc2a4d12ee7ad630ddb651ce6e / 7022-7137
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/005c43980edf3fcc2a4d12ee7ad630ddb651ce6e","sourcedb":"CORD-19","sourceid":"005c43980edf3fcc2a4d12ee7ad630ddb651ce6e","text":"Subsequently, ligand exchange was carried out to replace the hydrophobic TOPO ligands with hydrophilic MPA ligands.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T45","span":{"begin":0,"end":115},"obj":"Sentence"},{"id":"TextSentencer_T45","span":{"begin":0,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T45","pred":"source","obj":"CORD-19-Sentences"},{"subj":"TextSentencer_T45","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T30","span":{"begin":103,"end":106},"obj":"Disease"},{"id":"T67375","span":{"begin":103,"end":106},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0019124"},{"id":"A11119","pred":"mondo_id","subj":"T67375","obj":"http://purl.obolibrary.org/obo/MONDO_0019124"},{"subj":"T30","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T67375","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecce93","default":true},{"id":"CORD-19-PD-MONDO","color":"#b493ec"}]}]}}